Influence of 99mTc-tetrofosmin SPECT myocardial perfusion imaging on the prediction of future adverse cardiac events

Journal of Nuclear Cardiology

Volumn 16, Issue 4, 2009, Pages 540-548

  Jain, Diwakar ^a   Lessig, Harry ^b   Patel, Riti ^a   Sandler, Leonard ^c   Weiland, Fred ^d   Edell, Steven L ^e   Oates, M Elizabeth ^f   O'Malley Tysko, Erin ^c   Khutoryansky, Natalie ^g   Jacobson, Arnold F ^g  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b DEBORAH HEART AND LUNG CENTER   (United States)

^c Sutter Roseville Hospital ^*

^d Sutter Roseville Hospital   (United States)

^e Women's Imaging Center of Delaware   (United States)

^f UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^g GE HEALTHCARE   (United States)

Author keywords

99mTc tetrofosmin; adversecardiac events; Myocardial perfusion imaging; Prognosis

Indexed keywords

TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ACCURACY; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOLOGIC STRESS TESTING; PREDICTION; PRIORITY JOURNAL; REST; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; AGED; CARDIOLOGY; CLINICAL TRIAL; EXERCISE TEST; FOLLOW UP; METHODOLOGY; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PHASE 3 CLINICAL TRIAL; PROGNOSIS; RISK; TIME; TREATMENT OUTCOME;

AGED; CARDIOLOGY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; RADIOPHARMACEUTICALS; RISK; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 70249121432     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-009-9080-2     Document Type: Article

References (20)

1. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.
2. Jain D, Zaret BL. Nuclear imaging in cardiovascular medicine. In: Rosendorf C, editor. Essentials of cardiovascular medicine. 2nd ed. Totowa, NJ: Humana Press; 2005. p. 221-44.
3. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: The evidence. Eur J Nucl Med Mol Imaging 2004;31:261-91.
4. Berman DS, Shaw LJ, Germano G. Nuclear cardiology. In: Fuster V, Alexander RW, O'Rourke RA, editors. Hurst's: The heart. 10th ed. New York: McGraw Hill; 2001. p. 525-65.
5. Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, Sciammarella MG, et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 2004;11:414-23.
6. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol 2004;43:200-8.
7. Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Huurman A, et al. Risk stratification of patients with angina pectoris by stress 99m Tc-tetrofosmin myocardial perfusion imaging. J Nucl Med 2005;46:2003-8.
8. Galassi AR, Azzarelli S, Tomaselli A, Giosofatto R, Ragusa A, Musumeci S, et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am J Cardiol 2001;88:101-6.
9. Gibbons RJ, Hodge DO, Berman DS, Akinboboye OO, Heo J, Hachamovitch R, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999;100:2140-5.
10. Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: Results from the multicenter registry of 4,728 patients. J Nucl Med 2003;44:134-9.
11. Galassi AR, Grasso C, Azzarelli S, Ussia G, Moshiri S, Tamburino C. Usefulness of exercise myocardial scintigraphy in multivessel coronary disease after incomplete revascularization with coronary stenting. Am J Cardiol 2006;97:207-15.
12. Schinkel AF, Elhendy A, Bax JJ, van Domburg RT, Huurman A, Valkema R, et al. Prognostic implications of a normal stress technetium-99m tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization. Am J Cardiol 2006;97:1-6.
13. Califf RM, Armstrong PW, Carver JR, D'Agostino RB, Strauss WE. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purpose of risk factor management. J Am Coll Cardiol 1996;27:964-1047.
14. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999;33:1348-59.
15. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
16. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
17. Port SC, editor. Imaging guidelines for nuclear cardiology procedures, part 2. J Nucl Cardiol 1999;6:G49-84
18. Gibbons RJ, Abrams J, Chatterjee K, Deedwania PC, Douglas JS, Ferguson TB Jr, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-68.
19. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 2005;45:722-9.
20. Greenberg PS, Ellestad MH, Clover RC. Comparison of the multivariate analysis and CADENZA systems for determination of the probability of coronary artery disease. Am J Cardiol 1984;53:493-6.